Measured by its binding ability in a functional ELISA. Immobilized Cynomolgus / Rhesus BCMA hFc(Cat:90103-C02H) at 2 μg/ml (100 μl/well) can bind Human BAFF/BLyS hFc(Cat:10056-H01H),Biotinylated, the EC50 of Human BAFF/BLyS hFc,Biotinylated is 1.0-6.0 ng/mL(Routinely tested). |
![]() |
Immobilized Recombinant Cynomolgus / Rhesus TNFRSF17 / BCMA Protein (Fc Tag) (Cat: 90103-C02H) at 2μg/mL (100 μl/well) can bind Recombinant Human BLyS / TNFSF13B Protein (Fc & AVI Tag), Biotinylated (Cat: 10056-H42H-B), The EC50 is 1.5-6 ng/mL (Routinely tested). |
Immobilized Recombinant Cynomolgus / Rhesus TNFRSF17 / BCMA Protein (Fc Tag) (Cat: 90103-C02H) at 2 μg/mL (100 μL/well) can bind biotinylated Anti-BCMA Antibody, Human IgG1, the EC50 is 20-80 ng/mL (Routinely tested). |
Immobilized Recombinant Human APRIL/TNFSF13 Protein (His Tag) (Cat: 10610-H07H2) at 2 μg/mL (100 μL/well) can bind Recombinant Rhesus TNFRSF17 / BCMA Protein (Fc Tag) (Cat: 90103-C02H), the EC50 is 0.5-3.0 ng/mL (QC tested). |
Novak AJ, et al. (2004) Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival. Blood. 103 (2): 689–94.
O'Connor BP, et al. (2004) BCMA is essential for the survival of long-lived bone marrow plasma cells. J Exp Med. 199(1): 91-8.
Moser K, et al. (2006) Stromal niches, plasma cell differentiation and survival. Curr Opin Immunol. 18(3): 265-70.
400-829-0116